STENOTROPHOMONAS MALTOPHILIA TRIMETHOPRIM-SULFAMETHOXAZOLE RESISTANCE IN A CRITICALLY ILL POPULATION

被引：0
|
作者：
Magrum, BrookeAnne [1 ]
Elefritz, Jessica [2 ]
Hanks, Christine [2 ]
Murphy, Claire [2 ]
Stevenson, Kurt [2 ]
机构：
[1] Ohio State Univ, Wexner Med Ctr, Columbus, OH 43210 USA
[2] Ohio State Wexner Med Ctr, Columbus, OH USA
来源：
CRITICAL CARE MEDICINE | 2020年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
599
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Clinical implications of Stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: a study of 69 patients at 2 university hospitals
    Tsiodras, S
    Pittet, D
    Carmeli, Y
    Eliopoulos, G
    Boucher, H
    Harbarth, S
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2000, 32 (06) : 651 - 656
  • [22] Class 1 integrons increase trimethoprim-sulfamethoxazole MICs against epidemiologically unrelated Stenotrophomonas maltophilia isolates
    Barbolla, R
    Catalano, M
    Orman, BE
    Famiglietti, A
    Vay, C
    Smayevsky, J
    Centrón, D
    Piñeiro, SA
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (02) : 666 - 669
  • [23] Increase in the Prevalence of Resistance Determinants to Trimethoprim/Sulfamethoxazole in Clinical Stenotrophomonas maltophilia Isolates in China
    Hu, Li-Fen
    Chen, Guo-Sheng
    Kong, Qin-Xiang
    Gao, Li-Ping
    Chen, Xi
    Ye, Ying
    Li, Jia-Bin
    PLOS ONE, 2016, 11 (06):
  • [24] Prevalence of trimethoprim/sulfamethoxazole resistance genes among Stenotrophomonas maltophilia clinical isolates in Egypt
    Elsheredy, Amel
    Elsheikh, Azza
    Ghazal, Abeer
    Shawky, Sherine
    ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA, 2022, 69 (01) : 56 - 60
  • [25] Fluoroquinolones versus trimethoprim-sulfamethoxazole for the treatment of Stenotrophomonas maltophilia infections: a systematic review and meta-analysis
    Ko, J-H.
    Kang, C-I.
    Cornejo-Juarez, P.
    Yeh, K-M.
    Wang, C-H.
    Cho, S. Y.
    Gozel, M. G.
    Kim, S-H.
    Hsueh, P-R.
    Sekiya, N.
    Matsumura, Y.
    Lee, D-G.
    Cho, S-Y.
    Shiratori, S.
    Kim, Y-J.
    Chung, D. R.
    Peck, K. R.
    CLINICAL MICROBIOLOGY AND INFECTION, 2019, 25 (05) : 546 - 554
  • [26] Successful desensitization of trimethoprim-sulfamethoxazole in Stenostrophomonas maltophilia osteomyelitis
    Kim, Sujeong
    Lim, Kyung-Hwan
    Kang, Min-Gyu
    Park, Han-Ki
    Cho, Sang-Heon
    Min, Kyung-Up
    Kim, Sae-Hoon
    Chang, Yoon-Seok
    ALLERGY ASTHMA & RESPIRATORY DISEASE, 2014, 2 (03): : 218 - 221
  • [27] MECHANISMS OF RESISTANCE TO TRIMETHOPRIM, THE SULFONAMIDES, AND TRIMETHOPRIM-SULFAMETHOXAZOLE
    THEN, RL
    REVIEWS OF INFECTIOUS DISEASES, 1982, 4 (02): : 261 - 269
  • [28] Global emergence of trimethoprim/sulfamethoxazole resistance in Stenotrophomonas maltophilia mediated by acquisition of sul genes
    Toleman, Mark A.
    Bennett, Peter M.
    Bennett, David M. C.
    Jones, Ronald N.
    Walsh, Timothy R.
    EMERGING INFECTIOUS DISEASES, 2007, 13 (04) : 559 - 565
  • [29] Monotherapy with minocycline or trimethoprim/sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections
    Hand, Elizabeth
    Davis, Hannah
    Kim, Ted
    Duhon, Bryson
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (04) : 1071 - 1075
  • [30] Evolution of Resistance against Ciprofloxacin, Tobramycin, and Trimethoprim/Sulfamethoxazole in the Environmental Opportunistic Pathogen Stenotrophomonas maltophilia
    Ochoa-Sanchez, Luz Edith
    Martinez, Jose Luis
    Gil-Gil, Teresa
    ANTIBIOTICS-BASEL, 2024, 13 (04):
12345